Longitudinal Study for the Development of Innovative Wearable Tools for Foetal Wellbeing Monitoring
- Conditions
- Foetal Wellbeing
- Interventions
- Device: TMSi PortiDevice: Bloomlife sensor
- Registration Number
- NCT03969433
- Lead Sponsor
- Bloom Technologies
- Brief Summary
The purpose of this study is to support the development of a new generation of the Bloomlife sensor, enabling continuous monitoring of foetal wellbeing.
Data is collected in four Phases, with different experimental setups. Recordings with investigational and reference devices are performed on the subjects, at different gestational ages.
The collected data is used for developing algorithms for the extraction of parameters descriptive of foetal wellbeing.
Clinical information related to subjects' pregnancy and foetal health is also collected.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 231
- Pregnant
- Gestational age of at least 20 weeks
- Singleton pregnancy
- Willingness to participate in the study
- Multiple pregnancy
- Implanted pacemaker or any other implanted electrical device
- History of allergies to silicone-based adhesives
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Phase I TMSi Porti Data collections are performed with TMSi Porti system and CTG (reference) Phases II-III-IV Bloomlife sensor Data collections are performed with the Bloomlife sensor and CTG (reference)
- Primary Outcome Measures
Name Time Method Accuracy and reliability in the detection of foetal movements Throughout the subject's participation in the study, from inclusion until delivery Foetal movements are detected from the collected sensor data and compared to the reference
Accuracy and reliability in the detection of foetal heart rate Throughout the subject's participation in the study, from inclusion until delivery Foetal heart rate is extracted from the collected electrophysiological data and compared to the reference
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Ziekenhuis Oost-Limburg
🇧🇪Genk, Limburg, Belgium